Activation of ligand-gated channels is initiated by the binding of small molecules at extracellular sites and culminates with the opening of a membrane-embedded pore. To investigate how perturbations at ligand-binding domains influence the gating reaction, we examined current traces recorded from individual NMDA receptors in the presence of several subunit-specific partial agonists. We found that low-efficacy agonists acting at either the glycine-binding or the glutamate-binding NMDA receptor subunits had very similar effects on the receptor's activation reaction, possibly reflecting a high degree of coupling between the two subunit types during gating. In addition, we found that partial agonists increased the height of all energy barriers encountered by NMDA receptors during activation. This result stands in sharp contrast to the localized effects that have been observed for pentameric ligand-gated channels and may represent a previously unknown mechanism by which partial agonists reduce receptor activity.
The mechanism by which the binding of small molecules at extracellular sites of ligand-gated channels triggers a conformational change in the receptor's membrane-embedded pore remains poorly characterized 1 . For ionotropic glutamate receptors, crystallographic studies have suggested that, on binding, the ligand initiates large-scale motions in the agonist-binding domains, which in turn prompt further intrasubunit or inter-subunit rearrangements and culminate with a widening of the channel pore 2, 3 . For the fast-gating nicotinic acetylcholine receptors (rise time, B1 ms), free energy considerations predict that the gating reaction proceeds as a potent wave of conformational change that begins at the agonist-binding sites and peaks in the pore but whose intermediate conformers are too ephemeral to be observed experimentally 4 . More recently, single-channel studies have invoked the existence of short-lived pre-open receptor states in the activation reactions of several fast-gating ligand-activated channels, including AMPA, glycine and acetylcholine receptors [5] [6] [7] . For the much slower-gating NMDA receptors (rise time, B20 ms), several fully liganded pre-open intermediates are observed routinely in single-channel records 8, 9 . More recently, these intermediates have been integrated in comprehensive gating schemes, thus defining a most probable temporal sequence in which they become populated during activation [10] [11] [12] [13] [14] [15] [16] . Still, the physical locations and the precise nature of the changes that underlie these kinetically defined transitions remain unknown.
NMDA receptors assemble as dimers of heterodimers and are composed of two glycine-binding subunits (GluN1) and two glutamatebinding subunits (GluN2) 17, 18 . The GluN2 subunits, of which four (A-D) have been characterized, endow functional receptors with characteristic kinetics and pharmacology 19, 20 . NMDA receptors are exceptional among ligand-gated channels in that they become active only after all agonist-binding sites have been occupied 21, 22 . Because of this dual agonist requirement and their notably slow kinetics, NMDA receptors present a unique opportunity for measuring the contributions of individual subunit types to kinetically resolvable gating transitions.
On the basis of kinetic analyses of single GluN1/GluN2B channels activated with subunit-specific ligands, it has been proposed that partial agonists are less effective at opening the pore because they slow down, in a subunit-specific manner, distinct pre-opening transitions 10 . More recently, kinetic analyses of single pentameric receptors have suggested that agonist efficacy affects only the first pre-opening step during gating and not the channel-opening step per se 6, 7 . These findings, and the better understanding of NMDA receptor gating that has emerged in recent years, motivated us to characterize in further detail the mechanism of partial agonism at NMDA receptors.
We found that, in contrast with the localized effects observed for partial agonists at pentameric ligand-gated channels 6, 7 , partial agonists resulted in long-ranging changes in the NMDA receptor gating sequence; however, agonists of similar efficacy initiated activations that had identical free energy profiles, regardless of the subunit type to which they bound. On the basis of these results, we suggest that the two subunit types are tightly coupled during gating and that agonist efficacy affects all of the activation steps detected. In light of the contained changes that have been recently reported for pentameric channels, such wide-spread effects may reflect a previously unknown mechanism for partial agonism at ligand-gated receptors.
RESULTS

GluN1 partial agonists lengthen two time components
Comprehensive characterization of the NMDA receptor kinetics requires that long periods of activity be recorded to accumulate large numbers of openings and closures. This is because, even when continuously exposed to maximally active concentrations of the physiological co-agonists glutamate and glycine, NMDA receptors reside in open conformations for only a fraction (o60%) of the observed time 8, 23 . In addition, a quantitative description of the kinetic mechanism of NMDA receptors involves the estimation of at least ten rate constants that differ by four orders of magnitude [10] [11] [12] [13] 16, 24 .
For these reasons, we chose to examine steady-state currents from channels with relatively high intrinsic open probability: recombinant GluN1/GluN2A receptors in cell-attached membrane patches (P o ¼ 0.4-0.8) 11, 15 exposed to saturating concentrations of agonists whose efficacies were at least 50% of those reported for glutamate or glycine. We focused first on the glycine-site ligands D-cycloserine (DCS, 10 mM, 75-93%, n ¼ 5) 25, 26 and 1-aminocyclopropane-1-carboxylic acid (ACPC, 0.1 mM, 80%, n ¼ 11) 27 because high-resolution structures have been reported for the isolated agonist-binding domain of the GluN1 subunit in complex with these two ligands 27, 28 . Notably, these studies suggested that, in contrast with the graded cleft closure induced by partial agonists at AMPA-type glutamate receptor subunits, partial agonists may stabilize fully closed cleft conformations at NMDA-type subunits, similar to those elicited by full agonists, thus leaving the mechanism of partial agonism at these receptors unresolved (Fig. 1a) 27 . We also recorded single-channel activity with saturating concentrations of the glycine-site partial agonists L-alanine (Ala, 1 mM, 79%, n ¼ 6) 29 and 1-aminocyclobutane-1-carboxylic acid (ACBC, 2 mM, 40%, n ¼ 11) 27 . We compared these records with those obtained with saturating concentrations of both glycine (0.1 mM) and glutamate (1 mM, n ¼ 5).
All of the partial agonists that we studied elicited NMDA receptor currents with unitary amplitudes that were similar to those elicited by full agonists (Fig. 1b and Table 1 ). This observation is consistent with the view that partial agonists elicit submaximal macroscopic currents from NMDA receptors entirely as a result of a decrease in receptor open probability (P o ), without changes in channel conductance, as is the case for the related AMPA-type channels 10, 30 . For each of the agonists that we studied, the mean P o was consistent with the lower efficacy estimated previously from whole-cell current measurements ( Table 1 ). This result suggested that the single-molecule behaviors captured in our dataset were sufficient to reproduce the average behaviors estimated from ensemble measurements. We used the entire sequence of single-channel currents in each file to estimate mean closed durations (MCT) and mean open durations (MOT) for each of the receptors that we observed. We found that partial agonists elicited lower P o values as a result of both longer closures and shorter openings ( Table 1) . This result is similar with the effects of partial agonists on both open and closed durations at pentameric ligand-gated receptors 6 . Although it was previously reported that no substantial changes occurred in MOT at GluN1/GluN2B receptors with partial agonists 10 , it is likely that this result reflected the much shorter openings of GluN1/GluN2B isoforms, which may have hampered the detection of statistically significant agonist-specific changes in this parameter.
To further probe the mechanism by which glycine-site partial agonists decreased receptor P o , we characterized the closed and open 10, 31, 32 (closed interval distributions with the overlaid probability density function and exponential components E 1 -E 5 calculated for glycine, DCS and Ala are illustrated for individual receptors in Fig. 1c ; for ACPC and ACBC, representative current traces and histograms, as well as a summary of changes in closed-time constants for all patches, are shown in Supplementary Fig. 1 ). Statistical analyses of these data showed that all of the partial agonists tested increased t E2 and t E3 Btwofold. In addition to the changes that were common to all of the GluN1 ligands that we tested, we also observed agonist-specific changes; t E1 modestly increased with DCS and Ala and t E4 increased Bthreefold for ACBC (Supplementary Table 1 ). These results suggest that partial agonists increased all closed durations in clusters, which contrasts with previous measurements at GluN1/GluN2B receptors, where the glycine-site partial agonists DCS and HA-966 increased only one (t E2 ) of the three intra-cluster closed time components 10 . Although it is possible that this discrepancy illustrates differences in gating between the two isoforms, it is more likely that statistical significance of differences in the other two components (t E1 and t E3 ) was obscured by the much higher variability and much lower open probability characteristic to GluN2B-containing receptors, particularly when observed in excised patches 20 . To determine whether the changes that we observed were subunit specific, we recorded single-channel currents from one-channel patches using glutamate-site partial agonists.
GluN2A partial agonists lengthen the same two components
For the GluN2 family of subunits, only one high-resolution structure has been solved. It illustrates a back-to-back heterodimer of the GluN1 and GluN2A agonist-binding domains, both assuming cleft conformations fully closed around glycine and glutamate, respectively 33 . To probe the mechanism of partial agonism at the glutamate site, we recorded cell-attached single-channel currents in the presence of saturating glycine (0.1 mM) and the glutamate site partial agonists L-homocysteate (HCA, 1 mM, 86%, n ¼ 10) 34 , SYM2081 (SYM, 2 mM, 72%, n ¼ 5) 34 , quinolinic acid (1 mM, 20-60%, n ¼ 8) 35 ,36 and homoquinolinic acid (HQA, 1 mM, 75%, n ¼ 5) 34 (Fig. 2a) . These agonists have macroscopic efficacies that are comparable to those of the glycine-site partial agonists that we had tested, and we reasoned that differences in magnitude would not confound possible differences in mechanism.
Representative single-channel traces obtained with glutamate-site partial agonists (HCA and SYM; Fig. 2b ; HQA and quinolinic acid; Supplementary Fig. 2 ) can be compared with the glutamate-elicited traces described above (Fig. 1b) . As with glycine site partial agonists, single-channel current amplitudes were not affected and partial agonism at the glutamate site was fully explained by a reduction in channel P o (Table 1) . Similarly, the observed lower P o was the combined result of both longer closures and shorter openings ( Table 1) . Interval distributions for all of the files analyzed revealed five closed and three or four open components. The closed interval distributions obtained with HCA and SYM were markedly similar to those obtained with glycinesite partial agonists and had significantly longer time constants for the same two exponential components E 2 and E 3 (P o 0.002; Figs. 2c and 3 and Supplementary Table 1 ; representative traces and histograms and a summary of closed-time changes for HQA and quinolinic acid are illustrated in Supplementary Fig. 2 ). Quinolinic acid treatment resulted in single-channel traces with high patch-to-patch variability and prevented us from characterizing its kinetic mechanism with accuracy. However, for the other seven partial agonists that we investigated, regardless of subunit specificity, we identified a statistically significant increase in t E2 and t E3 as a common mechanism for the observed decrease in P o .
A previous study of GluN1/GluN2A receptors in excised patches identified t E3 as the only closed time component increased by HQA treatment 37 . We detected only a small change for t E2 (from 1.74 ± 0.08 ms (n ¼ 5) for glutamate to 2.0 ± 0.1 ms (n ¼ 5) for HQA). However, as with the other partial agonists that we tested, this increase was statistically significant (P o 0.03; Supplementary Fig. 2 and Supplementary Table 1 ). On the basis of these results, we conclude that the binding of partial agonists at either the GluN1 or the GluN2A subunits has similar effects on NMDA receptor gating, at least at the level of closed time components.
Low-efficacy agonists shorten NMDA receptor openings To investigate the mechanism underlying the observed decrease in channel MOT in the presence of partial agonists, we examined in detail the open interval distributions for four of the eight partial agonists By comparing open interval distributions obtained with full agonists with those obtained with the glycine site (Ala) or the glutamate site (SYM) partial agonists, we found that partial agonists at either site significantly shortened the duration of the longer time component in each mode (Fig. 4b) . By comparing the frequencies with which t low , t medium and t high occurred, we observed that partial agonists also biased channels toward lower P o gating modes. However, as a result of the low number of modal shifts observed for each channel, this result was not statistically significant (P 4 0.05; Supplementary Table 2) .
Partial agonists have wide ranging effects on gating As previously described, our results are consistent with a minimal gating mechanism for fully liganded NMDA receptors composed of five closed (C [1] [2] [3] [4] [5] ) and two open states with superimposed, albeit infrequent, modal swings. Because we could not definitively resolve whether partial agonists lower MOT by only shortening openings in each mode or by a combined effect on open durations and a decreased frequency of higher P o modes, we chose to represent all observed openings with an aggregated open state (O) (Fig. 5a ). This approximation has no consequence on the estimated rate constants for transitions between closed conformations because within each mode, the two coupled open states are distal to agonist-binding [10] [11] [12] 16, 24, 38 . In this simplified model, however, the rate constants for transitions into and from the aggregated open state represented weighted averages of intra-and inter-mode transitions rather than microscopic opening rate constants. We used this operational model to identify the transitions sensitive to agonist efficacy.
By comparing the rate constants obtained for a glycine-site agonist (Ala) and a glutamate-site agonist (SYM), we found that these partial agonists changed the same transitions (Fig. 5a) differences in gating were observed between agonists, partial agonists at either subunit type generally decreased the activation rate constants C 3 -C 2 , C 2 -C 1 and C 1 -O and increased the deactivation rate constants C 1 'O and C 2 'C 1 ( Supplementary Fig. 3 and Supplementary Table 3) . A pictorial representation of the calculated relative free-energy profiles for these reaction mechanisms illustrates that partial agonists at either the GluN1 or the GluN2A subunits resulted in activations that were energetically very similar (Fig. 5b) .
In addition, comparing these with the calculated activation profile elicited by full agonists, it was readily apparent that partial agonists caused pervasive changes to the NMDA receptor activation reaction; they increased the height of all activation barriers and caused increased occupancies of closed pre-open states at the expense of open state occupancies. As a common trend for the partial agonists that we investigated, with the exception of the C 3 'C 2 deactivation step, which remained unchanged, all transitions located along the activation pathway were affected; those leading to open states were decreased and those leading away from open states were increased (Supplementary Table 3 and Supplementary Fig. 3 ). In contrast, among off-pathway rate constants, only the C 3 -C 5 rate constant was significantly decreased for all of the ligands tested, except DCS (P o 0.02). Functionally, the closed state C 5 represents the principal desensitized state of NMDA receptors and our observation that partial agonists decreased both the activation rate constants and the desensitization rate constant is consistent with previously reported effects of partial agonists on homomeric GluA2 receptors 5,39,40 . These results are collectively consistent with the hypothesis that the closed state C 3 represents fully liganded receptor conformations whose ligand-binding clefts are open, such that ligands can still dissociate and re-associate with measurable rates 24 . Furthermore, our results are also consistent with the premise that cleft closure, with simultaneous ligand entrapment, can be productive when it leads to activation (C 3 -C 2 ) or nonproductive when it promotes desensitization (C 3 -C 5 ) 41, 42 .
Paradoxically, although the kinetic model clearly estimates that both the activation and the desensitization rate constants are decreased by partial agonists, it also predicts increased desensitization of macroscopic responses as a consequence of increased occupancy of state C 3 from which receptors can desensitize (Fig. 5c) . To test this prediction, we measured and compared the kinetics of macroscopic desensitization in the presence of saturating concentrations of partial agonists.
Partial agonists accelerate macroscopic desensitization
To examine how partial agonists affect NMDA receptor macroscopic desensitization, we recorded whole-cell current traces during 5-s applications of glutamate in the continuous presence of Ala or applications of SYM in the continuous presence of glycine. Because measurements of macroscopic current decay can report on a range of mechanisms by which NMDA receptor responses are known to desensitize, we selected conditions in which the time-dependent decline in current was expected to reflect mostly the accumulation of receptors in microscopic desensitized states (C 5 and C 4 ). To minimize contributions by a zinc-dependent mechanism, to which GluN1/ GluN2A channels are particularly sensitive, or by a calcium-dependent (d) Cartoon representing rearrangements in quaternary structure possibly corresponding to the kinetic intermediates that we characterized. The activation pathway is imagined to consist of the aggregated closures of all ligand-binding domains (C 3 -C 2 ), movements in transmembrane helices or/and the linker regions (C 2 -C 1 ) and direct gating of the permeation pathway (C 1 -O) by fast oscillations of residues in the selectivity filter. Off-pathway intermediates result from nonproductive closures of the ligand-binding domains, perhaps fostered by concurrent rearrangements in the N-terminal domains. This model takes into account our previous observation that glutamate dissociates with measurable rates from state C 3 , but not others 24 , and the current results that partial agonists affect the C 3 -C 5 and C 3 -C 2 equilibria to the same extent and in a symmetrical manner. It also incorporates current knowledge of the role of the N-terminal domains in desensitization, the third transmembrane domain in activation and the selectivity filter in gating. mechanism brought about by disruption of endogenous calcium stores, we included metal chelators in both extracellular and intracellular solutions (EDTA and EGTA, respectively). In addition, knowing that channel open probabilities may decrease following cell break-in, we anticipated differences in current amplitudes between the intact cellattached preparation (represented by the model) and experimental currents. Keeping in mind these limitations, we examined the kinetics with which receptors desensitize in the continued presence of GluN1 or GluN2 partial agonists. Current traces elicited with either Ala or SYM in the presence of the corresponding full co-agonist declined significantly faster than interleaved controls, with time constants (glutamate/Ala, 1.11 ± 0.02 s, n ¼ 3, P o 0.001; SYM/glycine, 0.95 ± 0.05 s, n ¼ 3, P o 0.002; glutamate/ glycine, 1.70 ± 0.05 s, n ¼ 6) that were very similar to those predicted by the model (glutamate/Ala, 1.2 s; SYM/glycine, 1.2 s; glutamate/glycine, 1.7 s) (Fig. 5c) . Thus, the experimental measurements reproduced the model's prediction that, although partial agonists are less effective at promoting entry into the desensitized state, they elicit macroscopic currents that desensitize faster. The predicted mechanism is an increased occupancy of pre-open states (C 3 and C 2 ) from which desensitization can occur (C 3 -C 5 and C 2 -C 4 ); although the probability for a receptor to desensitize is smaller with partial agonists, more receptors have the chance to desensitize. Clearly, this result on macroscopic desensitization need not be a general effect of partial agonists, as this ensemble measurement is also influenced by changes in rate constants elsewhere in the system.
DISCUSSION
Structural studies of the isolated ligand-binding domains of several ionotropic glutamate receptor subunits have advanced the hypothesis that agonist-induced conformational changes in the ligand-binding modules represent the initial large-scale rearrangement that impels subsequent gating or/and desensitization transitions. It is unclear how the sequence of structural changes postulated to take place in the ligand-binding domain of one subunit coordinates with movements in the remaining three subunits. One hypothesis, supported by functional data for GluA2 homomeric channels, suggests that subunits can change conformation independently, such that subunits activate individually in random order, following unitary ligand-binding events 43 . However, this scenario may not apply to NMDA receptors, as these receptors require that all subunits be occupied with ligand before channels open 22 . Furthermore, our results indicate that perturbations in the ligand-binding domain of either subunit type have similar effects on the receptor's activation, suggesting similar roles for the ligand-binding domains of GluN1 and GluN2 subunits and possibly a high degree of coupling between the two.
If such intersubunit coupling exists, and given that most native glutamate receptors assemble as dimers of heterodimers, it may be that the kinetic transitions that we observed for fully liganded receptors represent conformational changes that occur first in one heterodimer (C 3 -C 2 ), with subsequent rearrangements in the remaining heterodimer (C 2 -C 1 ) resulting in a final widening of the pore (C 3 -O). This mechanism would allow for both high coupling between subunits in each heterodimer and relative independence of heterodimers. However, our results appear to be inconsistent with this hypothesis, as perturbations at either the GluN1 or GluN2 ligand binding sites asymmetrically affected the C 3 -C 2 and C 2 -C 1 equilibria, with only the forward rates being changed in the former and with both forward and reverse rates being changed in the latter. This result would rather suggest that the structural changes represented by these two equilibria are of a distinct nature.
We therefore suggest the alternative premise that the first kinetically resolvable transition during NMDA receptor gating (C 3 -C 2 ), which we found to be sensitive to the efficacy of agonist of either subunit type, may represent rearrangements in the ligand-binding domain of the entire receptor. In this scenario, the ligand-binding domains of all four subunits have to switch into high-affinity conformations before the subsequent rearrangements necessary for gating or desensitization can occur with measurable probability (C 2 -C 1 ). Structural information for regions other than the ligand-binding domains is currently lacking. However, functional data point strongly to gating-associated movements in additional locations to the hinged ligand-binding domains; conserved residues at the top of the third transmembrane domains and fast motions in the selectivity filters of transmembrane pores have been shown to be important for gating. Thus, the pre-open intermediates postulated in the kinetic scheme may represent stepwise changes at locations positioned along the longitudinal axis of the protein: all four ligand-binding domains assuming the active conformation (C 2 ) first, followed by movements in all four linker domains (C 3 ), and with final widening of the pore (Fig. 5d) . This sequence would allow perturbations at either ligand-binding domain to result in similar changes to the energetics of the entire gating reaction. It is also consistent with reports that the trajectory of the conformational wave that represents gating in the nicotinic acetylcholine receptor occurs along the longitudinal axis of the protein 4 .
We should note that the resolution of our recordings prevented us from detecting events shorter than 0.15 ms and that, as with all kinetic studies, the conclusions derived here apply for the examined resolution and models. For these reasons, we cannot exclude the possibility that, as was demonstrated for AChRs 6, 7 , NMDA receptors also visit, before opening, very brief states whose stability is agonist independent. Nevertheless, the mechanism that we propose, which does not explicitly include such brief pre-open intermediates, reproduces well that trajectory of the macroscopic response. Thus, it is likely that even if such states exist, they contribute negligibly to the NMDA receptor physiological response.
In summary, we found that partial agonists specific for either GluN1 or GluN2 subunits have indistinguishable and wide ranging effects on the NMDA receptor activation reaction. The similar effects of perturbations at either NMDA receptor subunit type suggest that the sequence of conformational changes that represents this receptor's activation may involve structural rearrangements that cannot be traced to individual subunits or separate dimers. The pervasive influence of agonists on all gating equilibria differs markedly from the localized effects observed at pentameric receptors and may represent a previously unknown mechanism by which partial agonists decrease the open probabilities of ligand-gated receptors.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Accession numbers. The structures that we used for the GluN1 ligandbinding domain in complex with glycine, DCS and 5,7-dichlorokynurenic acid are from the Protein Data Bank, with accession numbers 1PB7, 1PB9 and 1PBQ, respectively.
ONLINE METHODS
Cells and transfections. HEK cells (ATCC CRL-1573), a gift from A. Auerbach (University at Buffalo), were maintained in Dulbecco's Modified Eagle Medium (DMEM, Invitrogen) with 10% fetal bovine serum at 37 1C in a 5% CO 2 atmosphere and were passed when they reached 80-90% confluence. Passages 22-40 were used for transfections.
Plasmids encoding rat GluN1-1a (U08261) and rat GluN2A (M91561) NMDA receptor subunits were gifts from R. Wenthold (US National Institutes of Health) and A. Auerbach (University at Buffalo), respectively. Open reading frames were sub-cloned into pcDNA3(+) under the control of the CMV promoter. The complete sequence of each insert was confirmed periodically by sequencing.
Calcium precipitate-mediated transfections were carried out by incubating the cells for 2 h with mixtures consisting of 140 mM NaCl, 5 mM KCl, 0.75 mM Na 2 HPO 4 , 6 mM sucrose, 125 mM CaCl 2 , 25 mM HEPES/NaOH (pH 7.05) and B1 mg cDNA (NR1:NR2A:green fluorescent protein ¼ 1:1:1) per 35-mm dish. After removing the precipitate, the cells were grown 24-48 h in DMEM supplemented with 2 mM Mg 2+ . Before each experiment, cells were washed, bathed in phosphate-buffered saline and placed on the stage of an inverted microscope. Individual cells were selected visually on the basis of fluorescence intensity.
Electrophysiology. Single-channel currents were recorded with the cellattached patch-clamp technique. The electrodes were filled with (extracellular) solutions containing 150 mM NaCl, 2.5 mM KCl, 1 mM EDTA, 10 mM HEPES and agonists as indicated (adjusted to pH 8 with NaOH). Inward sodium currents were recorded after applying +100 mV through the recording pipette. Currents were amplified and low-pass filtered at 10 kHz (Axopatch200B, 4-pole Bessel), sampled at 20-40 kHz (National Instruments card PCI-6229, M Series) and recorded into digital files with QUB acquisition software (www.qub.buffalo.edu).
Macroscopic currents were recorded with the whole-cell patch-clamp technique. Glass electrodes were filled with (intracellular) solutions containing 135 mM CsF, 33 mM CsOH, 2 mM MgCl 2 , 1 mM CaCl 2 , 10 mM HEPES and 10 mM BAPTA (adjusted to pH 7.4 with CsOH). After reaching the whole-cell configuration, the voltage was clamped at -70 mV and cells were superfused with extracellular solutions using a lightly pressurized perfusion system that exchanged solutions in 0.3-0.5 s (BPS-8, ALA Scientific Instruments). Extracellular solutions contained 150 mM NaCl, 2.5 mM KCl, 0.01 mM EDTA and agonists as indicated (adjusted to pH 8 with NaOH). Peak and steady-state current amplitudes and desensitization time constants were estimated by fitting traces averaged for five or more sweeps with a mono-exponential function. Mean values obtained per each condition were compared with those obtained from the control.
Simulations. Macroscopic currents were simulated with the QuB software from 200 receptors (5 pA each) as time-dependent accumulation of receptors in the open state. Glutamate site agonist pulses were simulated as 5-s square steps from zero into saturation concentrations of agonist, as indicated for each. Prior to pulse application, all receptors occupied a resting unliganded state from which they could access state C 3 of the indicated gating scheme (Fig. 5a ) by proceeding sequentially along two identical binding steps, each of which were assumed to have the microscopic kinetics measured previously for glutamate: k + ¼ 1.7 Â 10 7 M À1 s À1 and k À ¼ 60 s À1 (ref. 24) . The kinetics of the macroscopic traces were quantified as described above for experimental currents.
Single-channel data selection and pre-processing. Each digital file was displayed with QUB software and inspected visually for simultaneous openings, signal-to-noise ratios, high-frequency artifacts and baseline drift. In the conditions tested, records consisted of long, almost solid bursts of activity separated by silent periods as a result of low receptor-desensitization rate constants (o10 s À1 ) and high P o in bursts (0.5-0.9). As a result, records originating from patches with two or more active channels contained many superimposed bursts and were easy to detect and exclude from further processing and analyses. Although QUB software can handle files with two or more active channels (provided that these have similar kinetics), such multi-channel records become computationally expensive for minutes-long records. For this reason, we aimed to obtain multiple records with no apparent double openings for each condition tested. From this set, only records which required minimum processing were selected, mostly because it proved to be more time-consuming to 'clean' a noisy file than to record a new one, particularly for the long files necessary for this study (average was B200,000 events per file).
Records with no apparent double openings were considered to originate from a single active receptor for the following reasons. First, in files where simultaneous openings were observed, the estimated time constant for the longest exponential component (E5) was substantially shorter, indicative of one channel opening while another was desensitized. Second, for files obtained with partial agonists in which no simultaneous openings were observed, t 5 had a similar duration to that observed in one-channel patches obtained with full agonists. Thus, although the partial agonists used decreased P o substantially and made it more tenuous to equate the absence of double openings with the presence of only one channel, we are confident that the files selected for analyses originated from an individual receptor.
To correct errors resulting from occasional high-frequency artifacts, periods of low signal-to-noise ratios or baseline drift, the selected records were processed as follows. Brief (0.05-0.15 ms) current spikes were replaced with either closed-or open-level currents, matching the level of adjacent events, using the 'erase' function. Longer portions (milliseconds to minutes) with low signal-to-noise ratios were deleted and the remaining flanking traces were preserved as separate segments in the processed file to indicate discontinuity in the record. Finally, baseline drifts were corrected by resetting the baseline to zero-current levels as necessary.
Preprocessed data were idealized in QUB with the SKM algorithm after digitally low-pass filtering at 12 kHz with an imposed conservative dead time (0.15 ms, 3-6 samples) across all files.
Time constants and relative areas. We chose to perform all our single-channel measurements with saturating concentrations of agonists to minimize possible effects resulting from differences in the receptor's affinity for the ligands tested. We assumed that at the high concentrations used closures that reflect agonist dissociation are much shorter and more infrequent relative to closures that reflect fully liganded conformations. On the basis of this assumption, we attributed all the kinetic differences observed for the various ligands to differences in ligand efficacy and not affinity.
Kinetic analyses of idealized records were performed with QUB software using the MIL algorithm. To determine the number of closed and open states required to best-fit the data in each digital file (one channel per file), we started to fit each file with a simple two-state model; to this we added closed and open states one at a time while monitoring the associated increase in log likelihood values. A minimal model was selected by arbitrarily imposing a threshold of ten log likelihood units per state added. Each of the files considered for statistical analyses had between 3 Â 10 5 and 6 Â 10 6 events. Values for the calculated time constants and relative area of closed and open components were calculated from the minimal models optimized as described above and were reported as mean ± s.e.m. for each agonist pair along with the corresponding sample size (n). These parameters are independent of the arrangement of states in the model (see example in Supplementary Fig. 4 ).
Rate constants. To estimate microscopic rate constants, it is necessary to postulate a reaction mechanism and to therefore presume the most likely path that receptors follow when transitioning from one state to another. This is necessary because each model reflects a particular physical reality and because the optimized rate constant values may depend on the arrangement of transitions in the model in some instances. For NMDA receptors, a kinetic model based on independently gating subunits was proposed. It postulates that, after becoming fully liganded, either the GluN2 (slow transition) or GluN1 (fast transition) can independently change conformation to become active (slow/fast or fast/slow) but must arrive at a pre-open conformation where both subunits have been activated before the pore opens and the receptor transitions into an open conformation 10 . We compared this model with a simple sequential model ( Supplementary Fig. 4) . We found that the linear model returned consistently higher log likelihood values despite having fewer parameters and the rate constants estimated with the two models were very similar. For these reasons, we used the simpler, linear model throughout our analyses. It was also useful that the linear model, having been derived entirely from statistical arguments, does not attribute any a priori physical importance for the postulated transitions. Estimated rate constants were reported as means ± s.e.m., along with the respected sample size.
Statistics. Changes in kinetics were evaluated using the two-tailed unpaired Student's t test between values obtained for a particular partial agonist and values for the same parameter obtained with the full agonists glutamate and glycine. Differences of means were considered to be significant at P o 0.05. We opted for individual t test comparisons rather than multiple ANOVA testing because, although we identified changes in kinetic parameters that were common to all of the conditions investigated, the magnitudes of the differences were agonist specific. This was expected because the efficacies of the agonists used were not identical and, in addition to changes that were common to all of the partial-agonists tested, we also observed agonist-specific changes. Because a multiple ANOVA analysis tests the null hypothesis by comparing individual sample means to the global mean for all conditions, it is not appropriate to assume that each tested parameter (time or rate constant) will have the same variance. For these reasons, we chose the t test to evaluate statistical significance and aimed to minimize the possibility of reaching an erroneous conclusion by increasing the number of partial agonists tested at each site.
Bar graphs (Fig. 3 and Supplementary Figs. 1 and 2) were constructed by normalizing the mean value of the kinetic parameter illustrated to the mean value for the glutamate/glycine pair. Energy landscapes (Fig. 5b) were graphed by calculating and plotting changes in free energies relative to the free energies of the closed states C 3 , the first di-liganded state to be populated during activation. Calculations were carried out with the rate constants illustrated in Figure 5a and Supplementary Table 3 and the relationship DG 0 ¼ ÀRT ðln K eq Þ, where R is the molar gas constant, T is the absolute temperature and K eq is the equilibrium constant of the transition considered, calculated as the ratio of the forward to reverse rate constants. Barrier heights (E z ) were of arbitrary magnitude and were represented as E z ¼ DG o + (10 À lnk + ). Wells and peaks were arbitrarily positioned at equal distances along the reaction coordinate and the plots for each agonist pair were slightly shifted horizontally to optimize visibility. The notation that we used for NMDA receptor subunits is that currently recommended by the International Union of Basic and Clinical Pharmacology 18 (www.iuphar.org). The notation that we used for the kinetic components is from reference 44.
